73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers
Researchers identify potential gene marker for treating pancreatic cancer

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre
Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh

Study validates first-ever predictive AI biomarker of androgen deprivation therapy benefit in prostate cancer

by University Hospitals Cleveland Medical CenterProstate cancer cells. Credit: NIH Image GalleryData from a new study published inNEJM Evidenceshows promise for personalized use of sh
New delivery strategy may improve chemotherapy for acute myeloid leukemia

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG
Researchers develop CAR T cells that fight prostate cancer in bone

Researchers develop CAR T cells that fight prostate cancer in bone

by H. Lee Moffitt Cancer Center & Research InstituteBTN expression and spontaneous gamma/delta T cell infiltration in prostate tumors. (A) Bioinformatic analysis of TCR gamma variable regions

Researchers develop CAR T cells that fight prostate cancer in bone

by H. Lee Moffitt Cancer Center & Research InstituteBTN expression and spontaneous gamma/delta T cell infiltration in prostate tumors. (A) Bioinformatic analysis of TCR gamma variable regions
Breast cancer risk models may incorrectly classify many women

Breast cancer risk models may incorrectly classify many women

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainBreast cancer risk estimates for individual women vary substantially depending on which risk assessment model is used, an

Breast cancer risk models may incorrectly classify many women

byUniversity of California, Los AngelesCredit: Unsplash/CC0 Public DomainBreast cancer risk estimates for individual women vary substantially depending on which risk assessment model is used, an
Testosterone therapy may protect against breast cancer in trans masculine individuals

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c
Drugs for invasive breast cancer 'could treat earliest stages of the disease'

Drugs for invasive breast cancer 'could treat earliest stages of the disease'

by Emma Thorne,University of NottinghamMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaDrug

Drugs for invasive breast cancer 'could treat earliest stages of the disease'

by Emma Thorne,University of NottinghamMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaDrug
Non-invasive device more effective for early detection of lymphedema after breast cancer

Non-invasive device more effective for early detection of lymphedema after breast cancer

byCleveland ClinicCredit: Cleveland ClinicSome breast cancer survivors may experience lymphedema, a condition that causes painful swelling of their arm or hand after undergoing surgery or radiat

Non-invasive device more effective for early detection of lymphedema after breast cancer

byCleveland ClinicCredit: Cleveland ClinicSome breast cancer survivors may experience lymphedema, a condition that causes painful swelling of their arm or hand after undergoing surgery or radiat
Breakthrough in understanding of how cancer spreads could lead to better treatments

Breakthrough in understanding of how cancer spreads could lead to better treatments

by Cancer Research UKNALCN loss-of-function in aggressive cancers.a, Differential gene expression between normal PROM1+gastric cells andP1KP-GAC cells (downregulated ion channels are

Breakthrough in understanding of how cancer spreads could lead to better treatments

by Cancer Research UKNALCN loss-of-function in aggressive cancers.a, Differential gene expression between normal PROM1+gastric cells andP1KP-GAC cells (downregulated ion channels are
A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl
Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

byUniversity of TsukubaCredit: AI-generated imageThe location where cancer patients spend their last days can affect their "quality of death." However, it remains unclear whether the l

Comparison of survival times of advanced cancer patients with palliative care at home and in hospital

byUniversity of TsukubaCredit: AI-generated imageThe location where cancer patients spend their last days can affect their "quality of death." However, it remains unclear whether the l